According to DelveInsight’s latest analysis, Nipocalimab is expected to capture meaningful market share across both prevalent ...
The first dose of the COVID vaccine AZD1222 was associated with an increased risk for thrombotic thrombocytopenia syndrome (TTS) within 28 days after vaccination; however, no significant association ...
ME/CFS is characterized by Post-Exertional Malaise (PEM), where symptoms worsen after minimal activity. The condition is classified as a neurological disease often triggered by viral infections or ...